“Borisovskiy Zavod Medicinskikh Preparatov” JSC “Borisovskiy Zavod Medicinskikh Preparatov” JSC

“Borisovskiy Zavod Medicinskikh Preparatov” JSC“Borisovskiy Zavod Medicinskikh Preparatov” JSC

Brief view

Pharmaceutical factory Joint Stock Company “Borisovskiy Zavod Medicinskikh Preparatov” is the leading manufacture and the exporter of broad-spectrum drugs in the Republic of Belarus.

The factory was established in 1965. The company town of “Borisovskiy Zavod Medicinskikh Preparatov” JSC is above 11 hectares. Total employment at the factory is 2700 persons. Production volume in the actual prices for 2013 – 917.3 billion rubles (103.3 million USD)

Now JCS “Borisovskiy Zavod Medicinskikh Preparatov” is a modern dynamically developing pharmaceutical factory with new technology and high quality production and skilled personal.

slide 1

“Borisovskiy Zavod Medicinskikh Preparatov” JSC

Brief view

JSC“BZMP” holds participating shares in the companies:

slide 2

“Borisovskiy Zavod Medicinskikh

Preparatov” JSC

Belarus- German JV

Fresenius-Borisov-Dialysetechnik

(JV “FREBOR” OOO)

Participating shares of JSC

“BZMP” – 78.2%

OOO “Borisov KZ” (Kazakhstan)


“BZMP”– 30%

OOO “Boripharm” (RF)Participating shares

of JSC “BZMP”– 100%

BORIMED LTD(Kyrgyzstan)


“BZMP”– 50%


slide 3


Brief view The core business of “Borisovskiy Zavod

Medicinskikh Preparatov” JSC

• Ampoule production and powder for injections in

vials (antibiotics)

• tablet production

• production of liquid photochemical and soft

medical drugs

• production of hard capsule drugs

slide 4


Production volume in the actual prices in 2012- 747,8 billions rubles, in 2013 – 917,3 billion rubles (103,3 million USD).

Production volume in comparable pricesBillions rubles / growth rate to the previous year

Bill

on

s ru

ble

s

Short summary

slide 5


243134,3%181

128,1%

429176,4%

748174,4%

917122,5%

0

100

200

300

400

500

600

700

800

900

1 000

2009 64,8 млн.$

2010 2011 2012 2013 103,3 млн.$

time

bil

lon

s r

ub

ls

slide 6


Production pattern of quantities for 2013,

thousand pieces

1) 50,4%2) 27,4%

3) 12,8%

4) 3,0%

5) 1,4%

6) 1,6%

12) 0,3%

11) 0,2%

10) 0,3%

9) 0,5%

8) 1,3%7) 1,2% 1) vacuum filled ampoules

2) tablets

3) GMP ampoules

4) antibiotics in vials

5) iodine preparation

6) ointment, cream, gel (in tubes)

7) tinctures

8) capsule production

9) alcohol solution

10) oils

11) syrups and mixtures

12) others

Production pattern for 2013

Export patternRepublic of Belarus

Russian Federation

Kazakhstan

Uzbekistan

Tajikistan

Turkmenistan

Kyrgyzstan

Ukraine

Moldova

Armenia

Latvia

Lithuania

Estonia

Azerbaijan

Georgia

Afghanistan

USA

Iraq

Somalia

Yemen

Lebanon

Macedonia

Production was exported to 24 regions including CIS countries, Russia, nearby and foreign countries .

Vietnam DPRK EGYPT

slide 7


Portion of JSC “BZMP” in total Portion of JSC “BZMP” in total domestic production of medical drugs domestic production of medical drugs

for 2013for 2013(million(million packs)packs)

BZMP JSC keeps 36% of sales of medical drugs sold by domestic in the Republic of Belarus (on the basis of quantities).

slide 8


1 2 3 4 5 6 7 81 2 3 4 5 6 7 8 9 9

74,0

54,0

16,5 15,113,0 11,5 11,3

7,74,9

0,00

10,00

20,00

30,00

40,00

50,00

60,00

70,00

80,00

90,00

mill

ion

pac

ks

1. BZMP JSC

2. BelmedpreparatyRUE3. Farmland JS OOO

4. Ekzon RUE

5. Lekfarm SOOO

6. Nesvizskiy ZMP

7. Pharmtekhnologia

8. Minskintercaps RUE

9. DIALEK RUE

slide 9


Portion of BZMP JSC in total sales of medical drugs in the Republic of Belarus

for 2013 (million packs)

BZMP JSC keeps 26% for sales of medical drugs in the Republic of Belarus (on the basis of quantities)

11,39,1

7,7

5,3 4,9 4,2 3,5

74,0

54,0

16,515,1

13,011,5

7,9 7,8

4,8 4,4 4,2 3,6 3,6 3,5 3,2 2,9 2,8 2,7

0,0

10,0

20,0

30,0

40,0

50,0

60,0

70,0

80,0

90,0

producers

millio

n p

acks

1. BZMP JSC

2. Belmedpreparaty RUE

3. Farmland JS OOO

4. Ekzon Rue

5. Lekfarm SOOO

6. Nesvuzhskiy ZMP

7.Pharmtechnology

8. LubnyPharm

9.Pharmack

10. Pharmstandart

11. Minskintercaps

12. Berlin-Chemie

13. Dialeck

14. Luganskiy

15. Gedeon Richter

16. Sanofi Aventis

17.Mediosorb

18. Borshchahivskiy CPD

19. Bayer Consumer

20. NatureProdukt

21. Takeda

22. D-r Reddis

23.Actavis

24.KRKA

25.Gitomirskaya

11 22 3 3 44 55 6 7 6 7 88 9 10 119 10 11 12 12 13 13 14 14 15 16 15 16 17 17 18 18 19 19 20 21 20 21 22 22 23 23 24 24 2525

Kazakhstan

Russian Federation

Foreign countries

Uzbekistan

Azerbaijan

Turkmenistan

Kyrgyzstan

Moldova

Tajikistan

Armenia

Ukraine

Georgia

Russian Federation (52,9%) Kazakhstan (25,4%) Uzbekistan (2,2%) Azerbaijan (6,0%)Turkmenistan (3,2%) Kyrgyzstan (1,5%) Ukraine (0,4%) Moldova (2,5%) Armenia (1,1%) Tajikistan (1,1%)Georgia (2,5%) Foreign countries (USA, Afghanistan, Estonia, Latvia) (1,2%)

Export pattern Export ratio (%) in total volume exports

for 2013, thousand USD

In 2013 export of production amounted to 55.4 million USD.

slide 10


slide 11

“Borisovskiy Zavod Medicinskikh Preparatov” JSC Volume of export

In 2013 export volume amounts to 55.4 million US dollars or 105.6 % of the corresponding period last year.

Volume of exports

35,6106,2%

44,4124,5%

47,6107,4%

52,5110,2%

55,4105,6%

0,0

10,0

20,0

30,0

40,0

50,0

60,0

2009 2010 2011 2012 2013

года

mil

lio

ns d

oll

ars

TOP - 10 of medical drugs

Rating place Name

Sales volume for 2013(local sales + export)

In thousand USD

1 Valeriane extract, coated tablets 20 mg, №50 4527

2 Acetylsalicylic acid, tablets 500 mg №10 3639

3 Ceftriaxone, powder for injections, 1 g 3436

4 Analgin 50% №10 2553

5 Citramon-Borimed, tablets №6 2488

6Sodium chloride, 0,9% solution for injections, 5ml №10

1859

7 Cefazolin, powder for injections, 1 g 1833

8 Folic acid, tablets №50 1655

9 Lidocaine, solution for injections 2 ml 1590

10 Cyanocobalamin , solution for injections 1502

slide 12


DEALERS NET

“Borisovskiy Zavod Medicinskikh Preparatov”JSC

№ п/п

Country Number of

dealers

1 Kazakhstan 23

2 Russian Federation 10

3 Uzbekistan 10

4 Moldova 11

5 Georgia 7

6 Azerbaijan 7

7Other foreign countries

14

8 Turkmenistan 4

9 Kyrgyzstan 3

10 Tajikistan 5

11 Ukraine 2

12 Armenia 2

Total 98

Structure of dealer net

slide 13


Russian Federation

Kazakhstan

Tajikistan

Foreign countries

Georgia

Moldova Uzbekistan

Kyrgyzstan Azerbaijan

Ukraine

Turkmenistan

New medical drugsNew medical drugsName of drug Pharmacologic

2009

Zovasticor, tabl. Hypolipemic (lowers the level of cholesterol in the blood)

Chloropiramin, sol. for ing. Antihistamine preparation, inhibitor of H1- histamine receptors

Lidocaine, sol. for ing. For solution of cephalosporin antibiotics of III generation

Spasmatone, sol. for ing., tabl Analgesics and antispasmodics, non-narcotic

Ketozoral, tabl. Anti-fungous

Roxitromicyn – Borimed, tabl. Antibiotic macrolide

2010

Borinem, sol. for ing. Antibiotic carbopenem

Aspicard, tabl. Non-steroidal anti-inflammatory drugs – acetilsalicylic acid

Lansazole, caps. Inhibitor of proton pump

BoriVit, sol. for ing. Hypoglycemic means, decreases sugar in blood

Klindacil, sol. for ing. Antibiotic lincosamides group

2011

Lizinopril-Borimed,tabl. Inhibitor ACE (arterial hypertension, chronicle heart dysfunction)

Ribavirin-Borimed, caps. Intivirus preparation

Metformin-Borimed, tabl. For hypoglycemia treatment, per oral use, group Biguanid

Risperidon-Borimed, tabl. Antipsychotic

Sulpirid, caps. Antipsychotic

Sedative drops Combined sedative preparation


New medical drugsNew medical drugsNew medical drugsNew medical drugs

Name of drugPharmacologic

2012

Metromizol-Dent, gel combined antimicrobial agent for dentistry use

Gliclazide, tabl. 2nd generation sulfonylurea antidiabetic agent

Clindacyl, caps. lincosamide antibiotic

Clarithromycin, tabl. macrolide antibiotic

Bisoprolol, tabl. hypotensive, antiarrythmic and antianginal remedy

Ondansetron, tabl. antiemetic agent

Ethambutol, tabl. antituberculous remedy Choline Alfascerate, sol. for

inj. nootropic agent

slide 15


“Borisovskiy Zavod Medicinskikh Preparatov” JSC New medical drugsNew medical drugs

New medical drugsNew medical drugs Name of drug

Pharmacologic

2013

Valerianae Forte, tabl. sedative and soporific

Wite tablet, tabl. enterosorbent additional source of dietary fiber

ProctoMaz ointmentagent for the treatment of hemorrhoids

Meloxicam, tabl. non-steroidal anti-inflammatory drug

Magnekard,tabl. platelet aggregation inhibitors

slide 16

Sales volume pattern in the Republic of Belarus for 2013

4,1

84,1

11,8Enterprises of TP RUP “Pharmacia” - 366,5 bln. rubles

Direct shipments (hospitals, clinics,drugstores)- 17,9 bln. rubles

Other shipments (commercialenterprises) - 51,1 bln. rubles

Increase of sales for 2013(compared to 2012): Total increase of sales for 2013 – 130,7% (compared to 2012)Amounts to 435.6 billion rubles ( 49.0 mln. USD)

slide 17


Implementation of international standards

All main production sectors have GMP certificate and monitored in accordance with the quality standards of GMP.

The factory was certified with: • Quality and Operational Health and Safety Management Quality

Management Systems for medical drugs and biologically active additives conformity STB ISO 9001 -2009.

• Environment Management Systems for production and sales of medical drugs (ecological certificate) STB ISO 14001:2005

• Occupational Health & Safety System Certification for production and sale of medical drug and biologically active additives - STB 18001-2009

• Certificate of Conformity for Production of Valeriane extract tablets accordingly to the EC standards issued by Latvian Certification Centre.

slide 18



Award of the government of the Republic of Belarus

Award of government of the Republic of Belarus in the field quality 2011 is awarded to open joint stock company ‘Borisovskiy Zavod Medicinskikh Preparatov”. The company is awarded for its high efficient quality management and assurance of production of quality competitive products.

slide 19

Proposal on cooperation

slide 20


We offer to create a joint venture on the basis of existing sites of JSC “BZMP”:

1. Joint venture for production of solutions for injections in ampoulesCollective investment fund – 45.5 mln USDParticipant’s quotas:

JSC “BZMP” – 25.5 mln USD – 56.0% Investor – 20.0 mln USD – 44.0%JSC “BZMP”:a) hands over its existing production sites and equipment for production of

solutions for injections in ampoules;b) hands over the whole range of products in the form of solutions for

injections.Investor:a) pays the cost of the reconstruction of ampoule production;b) offers a new range of medical products.


Proposal on cooperation

2. Joint venture for production of medical products in the form of tablets

Collective investment fund – 23.2 mln USDParticipant’s quotas:

JSC “BZMP” – 8.2 mln USD – 35.4%Investor – 15.0 mln USD – 64.6%

JSC “BZMP”:a) hands over a part of its existing production sites and equipment for

production of medical products in the form of tablets;b) hands over a part of the range of products in the form of tablets.Investor:a) pays the cost of the reconstruction of existing tablet production;b) offers a new range of medical products.

We invite you for cooperation!

slide 21

Health, the dearest value is trusted to

us !

slide 22


Documents

“Borisovskiy Zavod Medicinskikh Preparatov” JSC “Borisovskiy Zavod Medicinskikh Preparatov” JSC